8-KThe WireRoutine
Bylaw Amendment
Filed Sep 19, 2022 · 3y ago · Accession 0001213900-22-057036
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- ORAMED PHARMACEUTICALS INC.
- Ticker
- ORMP
- CIK
- 1176309
- Form type
- 8-K
- Filing date
- Sep 19, 2022
- Report date
- Sep 15, 2022
- Document
- ea165945-8k_oramed.htm
- Size
- 477 KB